- Demise of Australia's Allco a Sign of More to Come
- The New Investment World: Together and Separate
- JPMorgan to Close Prop Desk, Lay Off Traders: Source
- Australian Government Faces Up to Grim Reality
- Stocks Rise as Asia Awaits US Election Outcome
- Bogle: Market Fundamentals Have 'Improved Radically'
- Dell Taking Further Steps To Cut Staff and Costs
- Marvel Posts Marvel-ous Profits, Sees Modest 2009
- Consumer Bankruptcies Soar in October
- Valliere: Can Obama Permanently Jump-start Confidence?
- At McCain Headquarters -- Johnny Cash!
- Time to Move to the Lawn
- Obama Appears and ... Nothing
- Lightning Round: Cisco, Morgan Stanley, Bristol-Myers and More
- Cramer's Outrage: The U.S. Treasury
- Cramer's Case for CAT
- Your First Move For Wednesday November 5th
- Why Staples Is the Superior Stock
- Capital Southwest mulls options for Lifemark Group
- HealthSouth lifts profit forecast for 2008
- HealthSouth 3Q earnings slide on year-earlier gain
- Philippine inflation eases for 2nd straight month
- Global Payments sets 2-cent quarterly dividend
- Princeton National sets 28-cent quarterly dividend
- Energy XXI sets 0.5-cent quarterly dividend
- ProLogis sets 51.75-cent quarterly dividend
- Sotheby's sets 15-cent quarterly dividend
- Healthcare Realty declares quarterly dividend
NEW YORK - Shares of nutritional and weight-loss supplements maker Herbalife Ltd. plunged Tuesday after the company disappointed Wall Street with a weaker-than-expected outlook.
Shares fell $5.99, or 23.5 percent, to $19.46 in Tuesday trading. The stock reached a near four-year low of $17.23 earlier in the trading session.
On Monday, the Los Angeles-based company reported third-quarter profit topping Wall Street forecasts on sales growth in the U.S., Brazil, China and Italy. But, it said the dollar's recent sharp appreciation against major world currencies will hurt fourth-quarter results.
Herbalife expects fourth-quarter profit between 65 and 75 cents per share, while Wall Street expected 87 cents per share. For the full year, the company expects profit of $3.50 to $3.55 per share, while analysts expected $3.68 per share.
In 2009, Herbalife expects profit of $3 to $3.20 per share.
Despite the massive sell-off, analysts mostly reaffirmed positive outlooks for the company, citing its growth potential.
"To be sure, a significant currency swing is the primary culprit, but decelerating volume growth in several key markets is also a factor," Goldman Sachs analyst Simeon Gutman said in a note to investors.
He reaffirmed a "Buy" rating, though, saying the relatively defensive business has growth prospects over the long term.
Jefferies & Co. analyst Douglas Lane, meanwhile, also reaffirmed a "Buy" rating and $39 price target but acknowledged that sales outside of China might be slowing down.


